DNMT3A Gene Acute Myeloid Leukemia Somatic DNMT3A Related Genetic Test sale cost 3000 AED
Oncopro BRAF Rapid Test sale cost 5150 AED Oncopro BRAF Rapid Test Cost 5,720 د.إ Original price was: 5,720 د.إ.5,150 د.إCurrent price is: 5,150 د.إ.
BARD1 Gene Breast Cancer Susceptibility to Genetic Test sale cost 4400 AED BARD1 Gene Breast Cancer Susceptibility to Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

DNMT3A Gene Acute Myeloid Leukemia Somatic DNMT3A Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 3,000 د.إ.

-46%

The DNMT3A gene plays a crucial role in the development of acute myeloid leukemia (AML), a type of cancer that starts in the cells that are supposed to mature into different types of blood cells. Mutations in the DNMT3A gene are among the most common genetic alterations found in AML patients, and these mutations are somatic, meaning they are acquired rather than inherited. These alterations can affect the gene’s normal function in DNA methylation, a process that is critical for controlling gene expression. As a result, the faulty DNMT3A gene can contribute to the uncontrolled growth of abnormal white blood cells characteristic of leukemia.

To aid in the diagnosis and management of AML, DNA Labs UAE offers a specialized genetic test that focuses on identifying somatic mutations in the DNMT3A gene. This test is a valuable tool for clinicians in tailoring treatment plans for patients, as the presence of DNMT3A mutations can influence prognosis and response to certain therapies. By detecting these mutations early, healthcare providers can make more informed decisions regarding intervention strategies, potentially improving patient outcomes.

The test is priced at 3000 AED and is conducted at DNA Labs UAE, a facility equipped with state-of-the-art technology for genetic testing. This investment in the DNMT3A related genetic test could be pivotal for patients diagnosed with AML, offering them a personalized approach to treatment that could significantly impact their recovery journey.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNMT3A Gene Acute Myeloid Leukemia Somatic DNMT3A Related Genetic Test

At DNA Labs UAE, we offer the DNMT3A Gene Acute Myeloid Leukemia Somatic DNMT3A Related Genetic Test at a cost of AED 3000.0.

Test Components

  • Price: 3000.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the DNMT3A Gene Acute Myeloid Leukemia Somatic DNMT3A Related Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by DNMT3A Gene Acute Myeloid Leukemia Somatic DNMT3A Related Genetic Test gene DNMT3A.

Test Details

The DNMT3A gene is responsible for producing an enzyme called DNA methyltransferase 3 alpha (DNMT3A), which is involved in DNA methylation and gene activity regulation. Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow. Some cases of AML are caused by genetic mutations, including mutations in the DNMT3A gene. These mutations are somatic, meaning they occur in the body’s cells and are not inherited.

NGS (Next-Generation Sequencing) is a genetic testing method that can analyze multiple genes simultaneously. In the context of DNMT3A-related AML, NGS genetic testing is used to identify mutations in the DNMT3A gene and other relevant genes associated with the development and progression of AML.

The DNMT3A-related NGS genetic test involves obtaining a sample, usually through a blood draw, and analyzing the DNA within the sample to identify any mutations or changes in the DNMT3A gene. This information aids in the diagnosis of AML and determining appropriate treatment options.

It is important to note that the presence of a DNMT3A mutation does not guarantee the development of AML, as other factors contribute to the disease. Additionally, not all cases of AML will have DNMT3A mutations. If you have specific concerns or questions about the DNMT3A gene, AML, or genetic testing, it is recommended to consult with a healthcare professional or a genetic counselor for personalized information and guidance based on your individual situation.

Test Name DNMT3A Gene Acute myeloid leukemia somatic DNMT3A related Genetic Test
Components
Price 3000.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for DNMT3A Gene Acute myeloid leukemia, somatic, DNMT3A related NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with DNMT3A Gene Acute myeloid leukemia, somatic, DNMT3A related NGS Genetic DNA Test gene DNMT3A
Test Details

The DNMT3A gene is a gene that provides instructions for making an enzyme called DNA methyltransferase 3 alpha (DNMT3A). This enzyme is involved in a process called DNA methylation, which helps regulate gene activity.

Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow. In some cases of AML, there can be specific genetic mutations, including mutations in the DNMT3A gene. These mutations are somatic mutations, meaning they occur in the cells of the body other than the reproductive cells and are not inherited.

NGS (Next-Generation Sequencing) is a type of genetic testing that can analyze multiple genes simultaneously. In the context of DNMT3A-related AML, NGS genetic testing can be used to identify mutations in the DNMT3A gene and other relevant genes that may be associated with the development and progression of AML.

The DNMT3A-related NGS genetic test involves obtaining a sample, usually through a blood draw, and analyzing the DNA within the sample to identify any mutations or changes in the DNMT3A gene. This information can help in diagnosing AML and determining appropriate treatment options.

It is important to note that the presence of a DNMT3A mutation does not necessarily mean a person will develop AML, as there are other factors involved in the development of the disease. Additionally, not all cases of AML will have DNMT3A mutations.

If you have specific concerns or questions about the DNMT3A gene, AML, or genetic testing, it is recommended to consult with a healthcare professional or a genetic counselor who can provide personalized information and guidance based on your individual situation.

SKU: TEST-4447 Category:

Related products